NOVAST LABS FDA Approval ANDA 091451

ANDA 091451

NOVAST LABS

FDA Drug Application

Application #091451

Application Sponsors

ANDA 091451NOVAST LABS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL37.5MG0PHENTERMINE HYDROCHLORIDEPHENTERMINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2012-09-21
LABELING; LabelingSUPPL2AP2017-05-31STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null15

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91451
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"PHENTERMINE HYDROCHLORIDE","activeIngredients":"PHENTERMINE HYDROCHLORIDE","strength":"37.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PHENTERMINE HYDROCHLORIDE","submission":"PHENTERMINE HYDROCHLORIDE","actionType":"37.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.